aTyr raises $45.8M

On Aug. 28, rare disease company aTyr Pharma Inc. (NASDAQ:LIFE) raised $45.8 million through two offerings. In a private placement, the company raised $15.6 million through the sale of 5.9 million shares at $2.65. The placement was led by Viking Global Investors and included participation from EcoR1 Capital and Redmile Group. Viking Global also purchased 2.3 million class X preferred shares at $13.25 for proceeds of $30.3 million...